ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CLRB Cellectar Biosciences Inc

3,32
0,23 (7,44%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cellectar Biosciences Inc CLRB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,23 7,44% 3,32 01:43:20
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,10 3,08 3,33 3,16 3,09
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
27.3.202411:40GLOBECellectar Biosciences Reports Financial Results for Year..
20.3.202411:40GLOBECellectar Biosciences to Announce 2023 Year End Earnings..
14.3.202413:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
04.3.202412:40GLOBECellectar Biosciences Reports High Rate of Complete..
15.2.202402:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202412:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
02.2.202412:03EDGAR2Form 8-K - Current report
31.1.202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30.1.202412:40GLOBECellectar Biosciences Announces Enrollment of the First..
25.1.202422:30EDGAR2Form 8-K - Current report
25.1.202412:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
22.1.202412:40GLOBECellectar Biosciences Reports Complete Central Nervous..
16.1.202412:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
12.1.202412:44GLOBECellectar Biosciences to Host Conference Call with Texas..
11.1.202412:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
09.1.202412:02EDGAR2Form 8-K - Current report
08.1.202412:30GLOBECellectar Biosciences Announces Positive Topline Data..
03.1.202414:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
19.12.202314:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
13.12.202302:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202314:30GLOBECellectar Biosciences Strengthens Intellectual Property..
05.12.202314:30GLOBECellectar Biosciences to Present at the Targeted..
29.11.202322:31EDGAR2Form 8-K - Current report
13.11.202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202312:45EDGAR2Form 8-K - Current report
31.10.202305:15EDGAR2Form EFFECT - Notice of Effectiveness
27.10.202322:40EDGAR2Form 8-K - Current report
25.10.202322:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
05.10.202322:45EDGAR2Form S-3 - Registration statement under Securities Act of..
02.10.202322:40EDGAR2Form DEF 14A - Other definitive proxy statements
22.9.202322:40EDGAR2Form PRE 14A - Other preliminary proxy statements
08.9.202323:17EDGAR2Form 8-K - Current report
21.8.202322:30EDGAR2Form 8-K - Current report
14.8.202314:45EDGAR2Form 8-K - Current report
14.8.202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29.6.202322:31EDGAR2Form 8-K - Current report
29.6.202312:03EDGAR2Form 8-K - Current report
29.6.202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202300:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock